Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by under-lying cause PART 07: Market segmentation by technique PART 08: Market segmentation by end-user • Market overview • Fertility clinics • Hospitals and research institutes PART 09: Geographical segmentation • Market overview • Male infertility market in Americas • Male infertility market in EMEA • Male infertility market in APAC PART 10: Decision framework PART 11: Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 12: Market trends PART 13: Vendor landscape • Competitive scenario PART 14: Key Vendor Analysis • ASKA Pharmaceutical • Halotech DNA • Merck Serono • Zydus Cadila Healthcare • Other prominent vendors PART 15: Appendix • List of abbreviations List of Exhibits Exhibit 01: Causes of male infertility Exhibit 02: Snapshot: Global male infertility market 2016-2021 Exhibit 03: Stages of infertility treatment Exhibit 04: Impact of various factors on male infertility market Exhibit 05: Types of sperm classification Exhibit 06: Global male infertility market 2016-2021 ($ millions) Exhibit 07: Key parameters for vendors entering the market Exhibit 08: Five forces analysis Exhibit 09: Stages of diagnosis of male infertility Exhibit 10: Facts related to oxidative stress Exhibit 11: Global male infertility market by end-users (2016) Exhibit 12: Risk factors in male infertility Exhibit 13: Opportunity analysis of global male infertility market Exhibit 14: Global male infertility market by geography 2016-2021 Exhibit 15: Snapshot: Global male infertility market by geography 2016-2021 Exhibit 16: Male infertility market in Americas 2016-2021 ($ millions) Exhibit 17: Male infertility market in EMEA 2016-2021 ($ millions) Exhibit 18: Male infertility market in APAC 2016-2021 ($ millions) Exhibit 19: Estimated number of individuals with diabetes worldwide in 2015 and 2040 (millions) Exhibit 20: Estimated cancer cases and deaths in US 2016 (in thousands) Exhibit 21: Obesity prevalence in US 2015 Exhibit 22: Impact of drivers Exhibit 23: Impact of challenges Exhibit 24: Change in world’s population by age 2010-2050 Exhibit 25: Key success strategies for vendors Exhibit 26: ASKA Pharmaceutical profile Exhibit 27: ASKA Pharmaceutical: Strength analysis Exhibit 28: ASKA Pharmaceutical: Strategy assessment Exhibit 29: ASKA Pharmaceutical: Opportunity assessment Exhibit 30: Halotech DNA: Profile Exhibit 31: Halotech DNA: Strength analysis Exhibit 32: Halotech DNA: Strategy assessment Exhibit 33: Halotech DNA: Opportunity assessment Exhibit 34: Merck Serono: Profile Exhibit 35: Merck Serono: Strength analysis Exhibit 36: Merck Serono: Strategy assessment Exhibit 37: Merck Serono: Opportunity assessment Exhibit 38: Zydus Cadila Healthcare profile Exhibit 39: ZydusCadila Healthcare: Strength analysis Exhibit 40: Zydus Cadila Healthcare: Strategy assessment Exhibit 41: ZydusCadila Healthcare: Opportunity assessment

ASKA Pharmaceutical, Halotech DNA, Merck Serono, Zydus Cadila Healthcare, AbbVie, Apricus Biosciences, Aytu BioScience, Bristol-Myers Squibb, CooperSurgical, Medical Electronic Systems, OvaScience, MedITEX, and Xytex Cryo International.